The company demonstrates how foundational nanoscience research becomes a market-ready technology in record time. Created in 2022 from microencapsulation innovations, this company has already deployed products to market and secured multi-million euro investment.

The company developed an intelligent and patient-aware BCI therapeutics platform able to diagnose and treat neurological disorders in real-time and with high resolution. The neural platform combines hardware and data analytics to decode and modulate neural networks, maximise time on therapy and effectively restore function or mobility for patients.